AND IFIT3 may also contribute to chemotherapy resistance in pancreatic ductal adenocarcinoma, with transcriptomic analysis revealing enriched pathways in high IFIT3 groups, such as inflammation, immune response, NF-κB signaling, and apoptosis (Wang et al., 2020). Here, NFKB1 is linked to pancreatic ductal adenocarcinoma.